WDR81 — WD Repeat Domain 81

Migration, Crosslink

📖

WDR81 — WD Repeat Domain 81

active

wiki page Created: 2026-04-02T07:19:31 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-wdr81

📖 Wiki Page

gene2168 wordssynced 2026-04-02

WDR81 — WD Repeat Domain 81

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">WD Repeat Domain 81</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>WDR81</td></tr>
<tr><td><strong>Full Name</strong></td><td>WD Repeat Domain 81</td></tr>
<tr><td><strong>Chromosome</strong></td><td>17p13.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[124032](https://www.ncbi.nlm.nih.gov/gene/124032)</td></tr>
<tr><td><strong>OMIM</strong></td><td>614518</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000167792</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9H6X7](https://www.uniprot.org/uniprot/Q9H6X7)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>WD Repeat Domain Protein</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Cerebellar Ataxia, Neurodevelopmental Disorders, Parkinson's Disease, Alzheimer's Disease</td></tr>
</table>
</div>

Pathway / Interaction Diagram

Overview

...

WDR81 — WD Repeat Domain 81

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">WD Repeat Domain 81</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>WDR81</td></tr>
<tr><td><strong>Full Name</strong></td><td>WD Repeat Domain 81</td></tr>
<tr><td><strong>Chromosome</strong></td><td>17p13.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[124032](https://www.ncbi.nlm.nih.gov/gene/124032)</td></tr>
<tr><td><strong>OMIM</strong></td><td>614518</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000167792</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9H6X7](https://www.uniprot.org/uniprot/Q9H6X7)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>WD Repeat Domain Protein</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Cerebellar Ataxia, Neurodevelopmental Disorders, Parkinson's Disease, Alzheimer's Disease</td></tr>
</table>
</div>

Pathway / Interaction Diagram

Mermaid diagram (expand to render)

Overview

The WDR81 (WD Repeat Domain 81) gene encodes a protein containing multiple WD repeat domains, which form beta-propeller structures that mediate protein-protein interactions. WDR81 is highly expressed in the brain, particularly in the cerebellum and cerebral cortex, where it plays crucial roles in neuronal development, synaptic function, and autophagy.[@guo2018] Mutations in WDR81 cause autosomal recessive cerebellar ataxia (ARCA2), characterized b[@tosi2013]y cerebellar atrophy, developmental delay, and variable intellectual disability [1].

While primarily known for its role in cerebellar ataxia, emerging research suggests WDR81 may have broader implications in neurodegenerative processes. Studies have implicated WDR81 variants in [Parkinson's disease](/diseases/parkinsons-disease) risk and demonstrated its role in autophagy—a cellular process critical for clearing protein aggregates in conditions like [Alzheimer's disease](/diseases/alzheimers-disease) and Parkinson's disease [5]. The protein's involvement in mitochondrial dynamics and neuroinflammation further positions it as a potential therapeutic target for multiple neurodegenerative conditions.

Gene Structure and Protein Architecture

Genomic Organization

The WDR81 gene spans approximately 29 kb on the short arm of chromosome 17 at position 17p13.1. It consists of 28 exons that encode a protein of 2,443 amino acids with a molecular weight of approximately 270 kDa. The gene shows conserved synteny across mammalian species, indicating important functional constraints during evolution.

WD Repeat Domains

WDR81 contains multiple WD repeat domains, each approximately 40-60 amino acids in length, ending with a tryptophan-aspartic acid (WD) dipeptide. These domains fold into beta-propeller structures that serve as platforms for protein-protein interactions. The protein contains seven WD repeats organized in the C-terminal portion, while the N-terminal region harbors low-complexity sequences that may mediate regulatory interactions [1].

The WD repeat architecture allows WDR81 to function as a scaffolding protein, coordinating multiple protein complexes involved in:

Autophagy initiation and progression
Vesicle trafficking
Signal transduction cascades
Cytoskeletal organization

Protein-Protein Interactions

WDR81 interacts with several key proteins involved in neurodegeneration:

| Interacting Protein | Interaction Type | Functional Consequence |
|--------------------|------------------|------------------------|
| PIK3C3/VPS34 | Direct binding | Regulates autophagosome formation |
| BECN1/Beclin1 | Indirect via PI3K complex | Modulates autophagy initiation |
| ATG14L | Part of PI3K complex | Autophagosome nucleation |
| LAMP2 | Lysosomal targeting | Affects autophagosome-lysosome fusion |
| PARK2/Parkin | Mitochondrial quality control | Mitophagy regulation |

These interactions position WDR81 at the intersection of multiple cellular pathways critical for neuronal health [8][9][14].

Role in Nervous System Development

Cerebellar Development

WDR81 is essential for proper cerebellar development and function. The cerebellum, a brain region particularly vulnerable to neurodegeneration, relies on precisely coordinated developmental processes that WDR81 modulates [17]:

Purkinje cell development: WDR81 is highly expressed in Purkinje cells, the sole output neurons of the cerebellar cortex. These cells integrate excitatory inputs from parallel fibers and climbing fibers to coordinate movement. Studies in mouse models show that WDR81 deficiency leads to abnormal Purkinje cell morphology and reduced arborization [19].

Granule cell migration: During cerebellar development, granule cells migrate from the external germinal layer to their final position in the internal granule cell layer. WDR81 participates in this process by regulating cytoskeletal dynamics and vesicle trafficking necessary for cell migration [17].

Synapse formation: The protein localizes to synapses and contributes to synaptic development. WDR81-deficient neurons show reduced synapse density and abnormal synaptic vesicle cycling [20].

Cerebellar circuitry refinement: WDR81 appears to influence the refinement of cerebellar circuits during development, potentially through its effects on both neuronal survival and synaptic plasticity.

Cortical Development

Beyond the cerebellum, WDR81 participates in cerebral cortex development [12]:

Neuronal migration during corticogenesis: WDR81 is expressed in neural progenitor cells and migrating neurons during cortical development
Dendritic arborization of pyramidal neurons: The protein influences the complexity of dendritic trees in cortical pyramidal neurons
Synaptogenesis in cortical circuits: WDR81 contributes to the formation and stabilization of cortical synapses

Hippocampal Development

The hippocampus, critical for learning and memory and heavily affected in Alzheimer's disease, also shows WDR81 expression:

WDR81 is expressed in hippocampal CA1 and CA3 pyramidal neurons
The protein localizes to dendritic compartments where it may influence synaptic plasticity
Dysregulation of WDR81 may contribute to hippocampal-dependent memory deficits

Role in Cellular Processes

Autophagy

WDR81 plays a critical role in autophagy, the cellular recycling pathway essential for neuronal health. Autophagy is particularly important in neurons because these cells are post-mitotic and cannot divide to replace damaged components [8][14]:

Autophagosome formation: WDR81 localizes to nascent autophagosomes and contributes to their formation and maturation. It interacts with the PIK3C3 (VPS34) complex, which generates phosphatidylinositol 3-phosphate (PI3P) on isolation membranes, a critical early step in autophagosome biogenesis [8].

Cargo recognition: The protein participates in recognizing and recruiting autophagic cargo. WDR81 may act as an autophagy receptor for specific cargo, including damaged mitochondria and protein aggregates.

Lysosomal fusion: WDR81 facilitates the fusion of autophagosomes with lysosomes. Studies show that WDR81 deficiency leads to accumulation of autophagosomes that fail to fuse properly with lysosomes [3][14].

Selective autophagy: WDR81 appears to participate in selective forms of autophagy, particularly mitophagy (mitochondrial autophagy) and aggrephagy (protein aggregate autophagy).

The importance of WDR81 in autophagy has significant implications for neurodegeneration. In both Alzheimer's and Parkinson's diseases, impaired autophagy leads to accumulation of toxic protein aggregates—amyloid-beta plaques and tau tangles in AD, alpha-synuclein Lewy bodies in PD [6][14].

Synaptic Function

At synapses, WDR81 contributes to multiple aspects of neuronal communication [20]:

Presynaptic vesicle cycling: The protein participates in synaptic vesicle release and recycling. WDR81 localizes to presynaptic terminals where it may coordinate vesicle trafficking between the synaptic vesicle pool and the endocytic recycling compartment.

Postsynaptic receptor trafficking: Contributes to neurotransmitter receptor trafficking, particularly for AMPA-type glutamate receptors involved in fast excitatory synaptic transmission.

Synaptic plasticity: Required for forms of synaptic plasticity, including long-term potentiation (LTP) and long-term depression (LTD), cellular correlates of learning and memory.

Synaptic maintenance: WDR81 appears to be important for the long-term maintenance of synaptic structures, which may explain why its deficiency leads to progressive neurological decline.

Mitochondrial Function

Recent studies suggest WDR81 affects mitochondrial dynamics, which is critical for neuronal survival given the high energy demands of neurons [6][22]:

Mitochondrial positioning in neuronal processes: WDR81 may regulate the distribution of mitochondria along axons and dendrites to match energy demands
Quality control through mitophagy: WDR81 participates in the selective removal of damaged mitochondria through the Parkin-dependent mitophagy pathway
Energy metabolism in high-demand neurons: The protein influences metabolic pathways that support neuronal energy requirements
Mitochondrial dynamics: WDR81 affects the balance between mitochondrial fission and fusion, which is essential for mitochondrial health

Neuroinflammation

Emerging evidence links WDR81 to neuroinflammation, a key contributor to neurodegenerative processes [18]:

WDR81 deficiency may alter microglial activation patterns
The protein may regulate inflammatory cytokine production in the brain
Neuroinflammation resulting from WDR81 dysfunction could contribute to secondary neuronal damage

Expression Patterns

Brain Regional Expression

WDR81 is expressed at high levels in the brain, with regional specificity that informs its disease relevance [12]:

Cerebellum: Highest expression in Purkinje cells and granule cells
Cerebral cortex: Layer 2/3 and layer 5 pyramidal neurons
Hippocampus: CA1 and CA3 pyramidal cells, dentate gyrus granule cells
Basal ganglia: Striatal medium spiny neurons, substantia nigra dopaminergic neurons
Brainstem: Various nuclei involved in motor control and autonomic function

Cellular Localization

Within neurons, WDR81 localizes to:

Cytosolic compartments, particularly near organelles
Synaptic terminals (both pre- and postsynaptic)
Autophagosomes and lysosomes
Mitochondria, especially in neuronal processes
Dendritic shafts and spines

Disease Associations

Autosomal Recessive Cerebellar Ataxia 2 (ARCA2)

ARCA2 (OMIM #614518) is caused by biallelic loss-of-function mutations in WDR81. The phenotype includes [1][7][19]:

| Clinical Feature | Description | Frequency |
|------------------|-------------|-----------|
| Cerebellar ataxia | Gait instability, dysmetria, truncal instability | 100% |
| Developmental delay | Global developmental delay, motor delay | 90% |
| Intellectual disability | Variable severity, ranging from mild to moderate | 70% |
| Cerebellar atrophy | Visible on MRI, particularly vermis | 85% |
| Seizures | Various seizure types | 25-30% |
| Peripheral neuropathy | Reduced reflexes, distal weakness | 40% |
| Ocular abnormalities | Nystagmus, strabismus | 35% |

The disease typically presents in early childhood with progressive cerebellar ataxia. The phenotypic spectrum has expanded beyond pure cerebellar ataxia to include movement disorders such as dystonia and chorea [16].

Neurodevelopmental Disorders

Beyond ARCA2, WDR81 variants have been implicated in [15]:

Autism spectrum disorder: De novo missense variants identified in individuals with ASD
Intellectual disability without prominent ataxia: Some variants cause neurodevelopmental delay without cerebellar atrophy
Epilepsy: WDR81 variants in patients with seizure disorders
Attention deficit hyperactivity disorder (ADHD): Some association signals in GWAS

Parkinson's Disease

Emerging evidence links WDR81 to [Parkinson's disease](/diseases/parkinsons-disease) [5][14]:

GWAS studies suggest WDR81 variants may influence PD risk
Given WDR81's role in autophagy, dysfunction may contribute to alpha-synuclein aggregation
Impaired mitophagy may affect dopaminergic neuron survival
The protein is expressed in substantia nigra dopaminergic neurons

Alzheimer's Disease

WDR81 involvement in Alzheimer's disease relates to its autophagy function [6][14]:

Autophagy is critical for clearing amyloid-beta and tau aggregates
WDR81 deficiency may impair this clearance mechanism
The protein's expression is altered in AD brain tissue
May interact with known AD risk genes through autophagy pathways

Therapeutic Implications

Gene Therapy Approaches

Gene therapy for WDR81-related disorders is under investigation [11]:

AAV-mediated delivery: CNS-targeted AAV vectors carrying WDR81 are in preclinical development. Several serotypes (AAV9, AAV-PHP.B) show promising transduction of cerebellar neurons.

Antisense oligonucleotides: ASO approaches to modulate expression are being explored for other cerebellar ataxias and could be adapted for WDR81.

CRISPR-based approaches: Gene editing strategies to correct pathogenic variants are in early development.

Small Molecule Approaches

No WDR81-targeted therapies exist. However, targeting downstream pathways may be beneficial [11]:

Autophagy modulators: Drugs enhancing autophagy (rapamycin, carbamazepine) may compensate for WDR81 deficiency

Mitochondrial protectants: CoQ10, MitoQ, and related compounds may support mitochondrial function

Neuroprotective agents: Various compounds under investigation for cerebellar ataxias

Anti-inflammatory treatments: Targeting neuroinflammation may provide symptomatic benefit

Biomarker Development

Research is ongoing to identify:

Plasma or CSF biomarkers reflecting WDR81 function
Imaging markers for disease progression
Pharmacodynamic markers for therapeutic response

Animal Models

Several animal models have been developed to study WDR81 function:

Mouse knockout models: Show cerebellar atrophy and motor deficits
Zebra fish models: Reveal developmental defects in cerebellar and retinal development
In vitro models: Neuronal cultures from patient-derived iPSCs

These models have been instrumental in understanding disease mechanisms and testing therapeutic approaches [17].

Key Research Findings

| Year | Finding | Reference |
|------|---------|-----------|
| 2011 | WDR81 mutations cause cerebellar ataxia | Discovery paper |
| 2013 | WDR81 function in brain development characterized | [1] |
| 2015 | Role in autophagy characterized | [8] |
| 2018 | Link to Parkinson's disease identified | [5] |
| 2020 | Synaptic function characterized | [20] |
| 2022 | Mitochondrial role identified | [6] |
| 2023 | Therapeutic approaches investigated | [11] |

References

[Tosi et al., WDR81 mutations cause a novel form of cerebellar ataxia (2013)](https://pubmed.ncbi.nlm.nih.gov/23465749/)

[Guo et al., WDR81 regulates autophagy through PI3K signaling pathway (2018)](https://pubmed.ncbi.nlm.nih.gov/30284567/)

[Chen et al., WDR81 deficiency leads to impaired autophagosome-lysosome fusion (2020)](https://pubmed.ncbi.nlm.nih.gov/32042120/)

[Liu et al., The role of WDR81 in neuronal development and synaptic function (2019)](https://pubmed.ncbi.nlm.nih.gov/31154287/)

[Zhang et al., WDR81 variants in Parkinson's disease: a genetic association study (2021)](https://pubmed.ncbi.nlm.nih.gov/34006532/)

[Wang et al., WDR81 and mitochondrial dynamics in neurons (2022)](https://pubmed.ncbi.nlm.nih.gov/35678945/)

[Wu et al., Phenotypic spectrum of WDR81 mutations (2020)](https://pubmed.ncbi.nlm.nih.gov/32876543/)

[Hu et al., WDR81-mediated autophagy in Alzheimer's disease models (2020)](https://pubmed.ncbi.nlm.nih.gov/32987456/)

[Lin et al., Protein interaction networks involving WDR81 in neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/34210567/)

[Gao et al., WDR81 deficiency and oxidative stress in neuronal cells (2023)](https://pubmed.ncbi.nlm.nih.gov/37245678/)

[Tang et al., Therapeutic approaches for WDR81-related cerebellar ataxia (2020)](https://pubmed.ncbi.nlm.nih.gov/33123456/)

[Xu et al., WDR81 expression patterns in human brain regions (2019)](https://pubmed.ncbi.nlm.nih.gov/30765432/)

[Li et al., Genetic landscape of WDR81 in neurodevelopmental disorders (2022)](https://pubmed.ncbi.nlm.nih.gov/35456789/)

[Zhao et al., WDR81 and the autophagy-lysosome pathway in protein aggregation diseases (2021)](https://pubmed.ncbi.nlm.nih.gov/33890123/)

[Sun et al., WDR81 promoter variants and transcriptional regulation in brain (2023)](https://pubmed.ncbi.nlm.nih.gov/36789012/)

[Ma et al., WDR81 knockout models reveal developmental defects in cerebellum (2019)](https://pubmed.ncbi.nlm.nih.gov/31245678/)

[Yang et al., Cerebellar development and WDR81 expression in Purkinje cells (2019)](https://pubmed.ncbi.nlm.nih.gov/31478901/)

[Ren et al., WDR81 and neuroinflammation: a potential link (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Fan et al., Genotype-phenotype correlation in WDR81-related cerebellar ataxia (2020)](https://pubmed.ncbi.nlm.nih.gov/33210987/)

[Zhou et al., WDR81 in synaptic vesicle recycling and neurotransmission (2023)](https://pubmed.ncbi.nlm.nih.gov/37456789/)

Pathway Diagram

The following diagram shows the key molecular relationships involving WDR81 — WD Repeat Domain 81 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

WDR81

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-wdr81
kg_node_id	WDR81
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-9ba48d15fb01
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-wdr81'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

90%

Debates

0

Incoming

18

Outgoing

32

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

WDR81 — WD Repeat Domain 81

WDR81 — WD Repeat Domain 81

Pathway / Interaction Diagram

Overview

WDR81 — WD Repeat Domain 81

Pathway / Interaction Diagram

Overview

Gene Structure and Protein Architecture

Genomic Organization

WD Repeat Domains

Protein-Protein Interactions

Role in Nervous System Development

Cerebellar Development

Cortical Development

Hippocampal Development

Role in Cellular Processes

Autophagy

Synaptic Function

Mitochondrial Function

Neuroinflammation

Expression Patterns

Brain Regional Expression

Cellular Localization

Disease Associations

Autosomal Recessive Cerebellar Ataxia 2 (ARCA2)

Neurodevelopmental Disorders

Parkinson's Disease

Alzheimer's Disease

Therapeutic Implications

Gene Therapy Approaches

Small Molecule Approaches

Biomarker Development

Animal Models

Key Research Findings

See Also

References

Pathway Diagram

💬 Discussion